Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of Topical Exosome-Containing Liquid in Healthy Volunteers
NCT07703969Phase 1Active, not recruiting
- Sponsor
- West Kazakhstan Marat Ospanov Medical University
- Start
- Sep 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 1, single-arm trial in burn injury, sponsored by West Kazakhstan Marat Ospanov Medical University. Primary endpoint: Number of Participants With Treatment-Emergent Adverse Events at Day 28. Started Sep 2026; status: active, not recruiting.
02
Conditions
burn injury
Beyond the preview
Go deeper on NCT07703969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07703969.